Onderneming Adaptive Biotechnologies Corporation
Aandelen
ADPT
US00650F1093
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,21 USD | +11,07% | -5,03% | -34,49% |
15/02 | ADAPTIVE BIOTECHNOLOGIES CORPORATION : JPMorgan Chase herhaalt koopadvies | ZM |
15/02 | Het verlies over het vierde kwartaal van Adaptive Biotechnologies neemt toe; omzet daalt; aandelen dalen | MT |
Vakgebied
Aantal werknemers: 709
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Minimal Residual Disease - Service
60,3
%
| 81 | 43,8 % | 103 | 60,3 % | +26,61% |
Immune Medicine - Collaboration
25,0
%
| 66 | 35,8 % | 43 | 25,0 % | -35,86% |
Immune Medicine - Service
14,7
%
| 32 | 17,1 % | 25 | 14,7 % | -21,46% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 185 | 100,0 % | 170 | 100,0 % | -8,11% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harlan Robins
FOU | Founder | 51 | 08-09-09 |
Chad Robins
CEO | Chief Executive Officer | 49 | 08-09-09 |
Julie Rubinstein
PSD | President | 52 | 01-04-11 |
Tycho Peterson
DFI | Director of Finance/CFO | 51 | 09-03-22 |
Zhou Yi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Public Communications Contact | - | - | |
Kyle Piskel
AUD | Comptroller/Controller/Auditor | 40 | 28-10-21 |
Stacy Taylor
LAW | General Counsel | 64 | 01-03-19 |
Sharon Benzeno
PRN | Corporate Officer/Principal | 50 | 01-09-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 01-02-13 |
Peter Neupert
BRD | Director/Board Member | 68 | 01-01-14 |
Michael Pellini
BRD | Director/Board Member | 58 | 13-02-18 |
Chad Robins
CEO | Chief Executive Officer | 49 | 08-09-09 |
Michelle Griffin
BRD | Director/Board Member | 58 | 01-03-19 |
Katey Owen
BRD | Director/Board Member | 55 | 17-03-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 145 092 271 | 142 101 405 ( 97,94 %) | 0 | 97,94 % |
Bedrijfsgegevens
Adaptive Biotechnologies Corp.
1165 Eastlake Avenue East
98109, Seattle
+206 659 0067
http://www.adaptivebiotech.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-34,49% | 419 mln. | |
-6,65% | 12,14 mld. | |
+82,29% | 3,94 mld. | |
-14,23% | 2,32 mld. | |
-23,73% | 2,19 mld. | |
-19,45% | 1,63 mld. | |
+32,37% | 1,14 mld. | |
+7,42% | 852 mln. | |
-11,75% | 545 mln. | |
+42,88% | 249 mln. |
- Beurs
- Aandelen
- Aandeel Adaptive Biotechnologies Corporation - Nasdaq
- Onderneming Adaptive Biotechnologies Corporation